New insider activity at Revvity ( (RVTY) ) has taken place on August 28, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Alexis Michas has recently sold 500 shares of Revvity stock, amounting to a total transaction value of $44,505.
Recent Updates on RVTY stock
Revvity, Inc. recently experienced a mixed financial outlook as highlighted in its Q2 earnings call. The company demonstrated strong performances in its software and life sciences segments, with record software orders and significant growth in life sciences, supported by robust cash flow management and aggressive share repurchases. However, Revvity is facing challenges, particularly in China, due to policy changes, tariffs, and declining revenues from academic and government sectors, which have contributed to a reduction in operating margins and adjusted EPS expectations. These challenges have led to a downward revision of price targets by analysts, reflecting concerns over the company’s ability to navigate these headwinds. Despite these issues, Revvity remains committed to innovation and strategic growth, as evidenced by its improved ESG rating and advancements in diagnostics.
Spark’s Take on RVTY Stock
According to Spark, TipRanks’ AI Analyst, RVTY is a Neutral.
Revvity’s overall stock score reflects a stable financial position and positive growth in certain segments, offset by challenges in diagnostics and high valuation. The technical indicators suggest a bearish trend, while the earnings call provided a mixed outlook with both strengths and risks.
To see Spark’s full report on RVTY stock, click here.
More about Revvity
YTD Price Performance: -20.46%
Average Trading Volume: 1,252,829
Technical Sentiment Signal: Sell
Current Market Cap: $10.59B